Article Text

Download PDFPDF

Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis
  1. Xiaoyun Gou1,2,
  2. Lei Yang1,2,
  3. Lingli Pan1,2,
  4. Dongqiong Xiao1,2
  1. 1 Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China
  2. 2 Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China
  1. Correspondence to Dr Dongqiong Xiao; m13881749494{at}163.com

Footnotes

  • XG and LY contributed equally.

  • Contributors XG and LY contributed to the conception and design of the study, as well as to the drafting of this article. LP contributed to the collection and analysis of the data. DX contributed to the conception and design of the study and approved the final version of the manuscript for submission for publication.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

View Full Text

Statistics from Altmetric.com

Strengths and limitations of the study

  • No consensus exists regarding the association between bronchopulmonary dysplasia (BPD) and cerebral palsy (CP) in children.

  • The clear and univocal definition of BPD may explain the differences of the results of studies which evaluated the association between BPD and CP in children.

  • The number of studies included is limited, and therefore, the results of the meta-analysis should be interpreted with caution.

  • Observational study designs rarely can establish causality.

Introduction 

Despite advances in obstetric and neonatal care, the prevalence of developing cerebral palsy (CP) was at approximately 0.2% during the past decades,1 and the aetiology of CP remains poorly understood. Evidence shows that prenatal factors, including maternal age,2 education,3 4 obesity,5–7 race,8 chorioamnionitis1 and hypertension9 contribute to CP.

Bronchopulmonary dysplasia (BPD) has been implicated as a potential neonatal factor of CP.10 BPD is common in preterm and low birthweight infants born at 24–26 weeks of gestation.11 The lung is in the canalicular stage from 16 to 28 weeks, and it is in the saccular stage from 28 to 36 weeks. Alveoli are not uniformly present until 36 weeks. Thus, premature birth and the initiation of pulmonary gas exchange arrest normal alveolar and distal vascular development, and subsequent BPD.11 Maternal infection, especially maternal chorioamnionitis was associated with an increased risk of BPD.12 The inconsistencies in the definition of BPD contribute to variation in incidence of BPD. BPD is a chronic lung disease developed after mechanical ventilation or oxygen inhalation usually occurring in certain premature neonates with respiratory distress syndrome. Some studies defined as oxygen dependency at 36 weeks postmenstrual age (PMA), yet, others defined as 28 or more days duration of oxygen dependency during hospitalisation.12 CP, cognitive delay and hearing loss are important and commonly reported adverse outcomes in very premature infants.13 It is postulated that BPD can lead to neonatal brain injury and subsequent CP.14

A number of studies have assessed the relationship between BPD and CP in premature infants, the association between BPD and CP was inconsistent. Some of the studies have not examined a significant association.15 16 For example, one study defined BPD as 28 days’ duration of oxygen dependency15 and reported insignificant association between BPD and CP, additionally, another study14 evaluated the association between BPD (oxygen dependency at 36 weeks) and quadriparas and diparesis, and reported the same result. However, any other studies17 18 showed a significant association between BPD and CP. We conducted a meta-analysis to evaluate the potential association between BPD and CP in preterm infants.

Methods

Retrieval of studies

The PubMed, EMBASE and Web of Science databases were searched through 1 September 2017. The search of BPD was performed using the following keywords and subject terms: ‘bronchopulmonary dysplasia’, or ‘BPD*’, or ‘lung dysplasia’, or ‘Dysplasia, Bronchopulmonary’ or ‘Bronchopulmonary Dysplasia’, using ‘OR’ to link relevant text within the search field. To acquire studies related to cerebral palsy, ‘OR’ was used to associate the keywords which included ‘cerebral palsy’, ‘Crebral pals*’, ‘spastic*’, ‘quadripleg*’ and ‘CP’. We combined these terms using ‘AND’ to retrieve the studies (see online supplementary material). We restricted the search to human studies published in English. The retrieved studies were screened by reading the titles and abstracts, and two authors (XG and LY) subsequently read the full text of the remaining publications independently and then discussed disagreements to reach a consensus.

Supplementary file 1

Patient and public involvement

Not required, a meta-analysis.

Study selection

The study inclusion criteria were as follows: (1) the study evaluated the association between BPD and the risk of CP in children, (2) the study was published in English, (3) case–control or cohort study design, (4) the study described the assessment of exposure and outcome, the relevant exposure included any type of BPD. Relevant outcome included any definition of CP. The association between exposure and outcome was reported by unadjusted and/or adjusted relative ratios (RRs) and corresponding 95% CIs, unadjusted and/or adjusted ORs estimates and 95% CIs reported the studies that could have been allowed RRs/ORs to be calculated (eg, number of cases of BPD events and total number of children with CP).

The exclusion criteria were as follows: (1) a review or meta-analysis or a case report, (2) the study was not published in English, (3) the article described an animal experiment study, (4) a study with overlapping data, (5) the articles were excluded with unusable data (eg, the articles were reported with the following unusable data, neurological lesion before discharge or CP between BPD and without BPD, we cannot know the exact result of the association between CP and BPD; neurodevelopmental outcomes (neuropsychological performance, neurodevelopmental disability) including but not limited to CP).

Data extraction

The data were independently extracted from the studies by two reviewers (XG and LY) and included the name of the first author, publication year, the country of the participants, study design, sample size, gestational age and/or birth weight, following years, BPD definition, primary outcome (the association between BPD and risk of CP) and adjusted confounders.

Quality evaluation

The two reviewers (XG and LY) independently used the Newcastle-Ottawa Scale (NOS)19 to examine all included studies for their methodological quality. The reviewers evaluated the quality score by examining the study population, comparability and evaluation of exposure and outcome, with a maximum score of 9. The reviewers resolved disagreements in the manner previously described.

Statistical analysis

The original studies included used ORs and/or RRs and 95% CIs to assess the association between BPD and the risk of CP in children. The ORs and RRs were directly considered as ORs when the outcome was rare.1 We pooled ORs and/or RRs of each study separately using the Der Simonian-Laird formula (random-effects model).20 Statistical heterogeneity21 between the studies was assessed using the Q and I2 statistics. Values of I2 >50% and p<0.1 indicated high heterogeneity.1 We conducted a stratified analysis based on study design (case–control, cohort), BPD type (oxygen dependency at 36 weeks’ PMA, 28 days’ duration of oxygen dependency during hospitalisation, severe BPD including mechanical ventilation at 36 weeks, no definition of BPD), diagnostic criteria for CP (age <2 years, other), confounding variables (gestational age, unadjusted estimated).

We used Egger’s22 and Begg’s23 tests to assess the publication bias which was considered to be statistically significant when p<0.05. We used Stata software V.12.0 (Stata Corp) to perform the statistical tests. We performed a ‘Test of Subgroup differences’ in software such as Review Manager V.5.3 (Cochrane).

Results

Literature search

We identified 1234 potential studies: 195 from PubMed, 523 from EMBASE, 515 from Web of Science and 1 additional study from the related reference. After careful screening, 11 studies that reported the association between BPD and the risk of CP in children were selected for inclusion in this study (see figure 1). These 11 included studies are summarised in table 1.

Figure 1

Flow chart for study selection.

Table 1

Characteristics of the included studies

Characteristics and quality of the included studies

The included studies were published between 1999 and 2017. Eleven studies evaluated the association between BPD and CP in preterm infants. Two15 16 of these studies reported no significant association. Eight of the included studies were cohort studies, and three15 17 18 of the studies were case–control studies of a high quality (NOS >5, online supplementary 2 and 3). All the studies evaluated the association between BPD and CP in preterm neonates with ORs.

BPD and CP

When the study results were analysed using random effects model, BPD was significantly associated with CP (figure 2). These infants were preterm.

Figure 2

Analysis of bronchopulmonary dysplasia (BPD) and cerebral palsy (CP).

Stratified analysis

A stratified analysis was conducted to determine whether there were any significantly different results across the subgroups considered (table 2). The case–control studies did not produce significant summary ORs (1.27; 95% CI 0.98 to 1.64, I2=72%), yet, a significant association was seen in cohort studies ORs (2.09; 95% CI 1.86 to 2.34, I2=83%). The subgroup difference was significant when stratified by study design (ORs, 1.27; 95% CI 0.98 to 1.64 vs ORs, 2.09; 95% CI 1.86 to 2.34; p<0.05, table 2).

Table 2

Pooled results of the associations between bronchopulmonary dysplasia and cerebral palsy in children

Six studies14 16 18 24–26 evaluated the association between BPD (oxygen dependence at 36 weeks) and CP in premature infants, with only one reporting16 no significant association (figure 2). One study15 evaluated the association between BPD (oxygen dependence at 28 days) and CP in premature infants with no significant association (OR 1.12, 95% CI 0.84, 1.49). Three studies17 27 28 evaluated the association (OR 2.80, 95% CI 2.08 to 3.79, I2=30.5%) without mentioning BPD definition, and two studies14 29 showed severe BPD or mechanical ventilation at 36 weeks (OR 3.44, 95% CI 1.56 to 7.60, I2=63.7%). The subgroup difference was significant when stratified by BPD definition (p<0.00001, table 2).

The definition of CP differed greatly among studies of preterm infants (table 2). Of the four studies14 16 24 28 that provided adequate information, four studies provided a minimum age of 2 years for diagnosing CP. Some studies confirmed the diagnosis by performing examination, while others did not. Some studies excluded children with congenital anomalies,15 16 28 while others14 24 did not specify any exclusion criteria.

Five studies of BPD (PMA) in premature infants reported ORs controlled for gestational age. Association between BPD and CP remains significant both adjusted or unadjusted by gestational age (ORs 2.64; 95% CI 2.27 to 3.08 vs ORs 1.48; 95% CI 1.28 to 1.70; p<0.00001, table 2).

Publication bias

Asymmetry and publication bias were evaluated by Egger’s and Begg’s tests (figure 3, figure 4). The pooled results did not support the presence of significant publication bias (all p>0.05, online supplementary 4).

Figure 3

The Egger’s test for publication bias. 

Figure 4

The Begg’s test for publication bias.

Discussion

To our knowledge, this article is the first meta-analysis of the relationship between BPD and risk of CP in children. The results of this meta-analysis, which included 11 studies, showed evidence that BPD appears to be associated with CP in preterm infants.

BPD might affect the neurodevelopmental outcome of infants through multiple pathways. A growing body of evidence supports that BPD contributes to neonatal brain injury.30 Experimental BPD with hypoxia leads to central nervous system damage, and subsequent CP.31 32 Indeed, preterm infants with BPD accompanied with hypoxia often had oligodendrocytes maturation arrest or injury,33–35 disruption of myelination and demyelination, which then caused white matter injury35 and impaired neurodevelopmental outcomes.32

To better understand the relationship between BPD and CP, it is crucial to develop consensus definitions of BPD. Most published reports do not apply specific diagnostic criteria for BPD, and as a group, these studies produced heterogeneous results. The results suggest that a stronger association is seen when used severe or mechanical ventilation at 36 weeks diagnostic criteria in the stratified analysis. The studies that do not include strict criteria may lead to an overdiagnosis of BPD which may contribute to the evidence of heterogeneity.

The definition of CP varied between studies; although CP can be difficult to diagnosis in children younger than 2 years, one study made the diagnosis in infants younger than 12 months. A consensus definition of CP is required.

Some studies report significant associations between BPD and CP after adjustments for potential confounders.15 16 18 25 26 28 Although gestational age appears to be a possible confounder, it may not lie directly in the causal pathway between BPD and CP. Gestational age can be considered as a confounder, as a premature baby is born at any gestational age and later may develop BPD. The study would falsely diminish the association between BPD and CP without considering gestational age as a confounder. BPD is associated with premature delivery and low gestational age which is associated with a host of intrinsic vulnerabilities within the brain that have been implicated in the pathogenesis of CP. Therefore, if low gestational age resulting in BPD plays a direct role in the pathogenesis of CP, then adjusting for gestational age will falsely diminish the observed association between BPD and CP. One study16 of BPD in premature infants found no association when controlling for the confounder variables, including gestational age. It is unclear if this is because BPD does not contribute independently to CP, or perhaps because gestational age lies on the causal pathway.

Other factors may interact with BPD in the pathogenetic pathway leading to CP. For example, child sex, IVH, Apgar score at 5 min, small for gestational age, which may contribute to CP, lie on the causal pathway. Accordino et al 36 demonstrated that premature spontaneous birth and iatrogenic preterm birth were significantly associated with CP. The differernces of the results contribute to neurological damage would be related to infection. Although the studies controlled for some confounder variables, many other factors that contributed to CP may not be excluded.

Our meta-analysis is subject to limitations as follows. First, we only included articles published in English. Second, there may be publication bias, incomplete ascertainment of published studies and errors in data abstraction. Third, the number of studies included is small, and therefore, the results of this meta-analysis should be interpreted with caution. Furthermore, the bias inherent to observational studies are not eliminated in a quantitative synthesis.

Our meta-analysis has some merits. First, the study evaluated the association between BPD and CP. Second, the study used stratified analysis to explore the heterogeneity source, and the different definition of BPD may contribute to the source of heterogeneity.

In conclusion, our pooled analyses provide evidence that BPD is significantly associated with CP in children. Future studies that consider additional factors are required to resolve this issue.

References

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.
  27. 27.
  28. 28.
  29. 29.
  30. 30.
  31. 31.
  32. 32.
  33. 33.
  34. 34.
  35. 35.
  36. 36.
View Abstract

Footnotes

  • XG and LY contributed equally.

  • Contributors XG and LY contributed to the conception and design of the study, as well as to the drafting of this article. LP contributed to the collection and analysis of the data. DX contributed to the conception and design of the study and approved the final version of the manuscript for submission for publication.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.